Are you Dr. Peterson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
333 Pine Ridge Blvd
Wausau, WI 54401Phone+1 715-847-2866
Summary
- Dr. Christopher Peterson, MD is an oncologist in Wausau, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Michigan. He is affiliated with Aspirus Wausau Hospital, Inc. and Aspirus Langlade Hospital.
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2003 - 2005
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2001 - 2003
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1998 - 2001
- Medical College of WisconsinClass of 1998
Certifications & Licensure
- MI State Medical License 2011 - 2025
- WI State Medical License 1999 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 130 citationsRituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402Brad S. Kahl, Fangxin Hong, Michael E. Williams, Randy D. Gascoyne, Lynne I. Wagner
Journal of Clinical Oncology. 2014-10-01 - 31 citationsRituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protoco...Michael E. Williams, Fangxin Hong, Randy D. Gascoyne, Lynne I. Wagner, John C. Krauss
British Journal of Haematology. 2016-06-01 - 11 citationsVcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.Julie E. Chang, Lakeesha Carmichael, KyungMann Kim, Christopher Peterson, David T. Yang
Clinical Lymphoma, Myeloma & Leukemia. 2018-01-01